BioTime Subsidiary OncoCyte Corporation Appoints Cavan Redmond To Its Board Of Directors
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT and TASE: BTX) announced the appointment of Cavan Redmond as an independent member of the Board of Directors of BioTime’s subsidiary OncoCyte Corporation. Mr. Redmond, 54, is a seasoned healthcare strategist who has held a number of global leadership positions.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.